AP
Anuja Patnaik
About Anuja Patnaik
Data last updated:
Anuja Patnaik is a Director at Adit Bioscience Private Limited (since 2015), Director at Cytoforge Therapeutics Private Limited (since 2025) and Designated Partner at Kurebio Llp (since 2024). The companies operate in Business Services. The largest current company by reported revenue is Adit Bioscience Private Limited at ₹24,210 (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 12 Oct 2015 | 2015 | ₹24,210 (FY 2024) | Active | |
| Director | 13 Jun 2025 | 2025 | Active | ||
| Designated Partner | 19 Feb 2024 | 2024 | Active |
Board colleagues of Anuja Patnaik
| Name | DIN | Company | Designation |
|---|---|---|---|
| Sanjukta Patnaik | 08157796 | Adit Bioscience Private Limited | Director |
| Mahin Amit Vasavada | 11152939 | Cytoforge Therapeutics Private Limited | Director |
| Umasish Mohanty | 11152940 | Cytoforge Therapeutics Private Limited | Managing Director |
| Mohammed Saleem | 03280515 | Kurebio Llp | Designated Partner |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Anuja Patnaik
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Anuja Patnaik
Anuja Patnaik currently holds 3 directorships: Adit Bioscience Private Limited (Director, since 12 Oct 2015, revenue ₹24,210 (FY 2024)); Cytoforge Therapeutics Private Limited (Director, since 13 Jun 2025); Kurebio Llp (Designated Partner, since 19 Feb 2024).
Anuja Patnaik was first appointed on 12 Oct 2015 as Director at Adit Bioscience Private Limited. The most recent appointment on record is 13 Jun 2025 at Cytoforge Therapeutics Private Limited.
The current boards of Anuja Patnaik's companies include Sanjukta Patnaik (Adit Bioscience Private Limited), Mahin Amit Vasavada (Cytoforge Therapeutics Private Limited), Umasish Mohanty (Cytoforge Therapeutics Private Limited), Mohammed Saleem (Kurebio Llp).